ストックスクリーナーアプリを入手
85.62
0.36%
0.07
前日終値:
$85.69
開ける：
$86.49
24時間の取引高:
33,913
Relative Volume:
0.06
時価総額：
$5.71B
収益：
-
当期純損益:
$-224.29M
株価収益率:
-21.95
EPS:
-3.9
ネットキャッシュフロー:
$-185.06M
1週間 パフォーマンス:
+6.26%
1か月 パフォーマンス:
+13.86%
6か月 パフォーマンス:
+13.40%
1年 パフォーマンス:
+7.73%
1日の値動き範囲:
$85.92
$86.49
1週間の範囲:
$80.02
$86.83
52週間の値動き範囲:
$55.53
$113.51
Nuvalent Inc Stock (NUVL) Company Profile
NUVL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NUVL
Nuvalent Inc
|
86.01 | 5.89B | 0 | -224.29M | -185.06M | -3.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.10 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.54 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
323.88 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
569.64 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
298.87 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-14 | アップグレード | UBS | Neutral → Buy |
| 2024-12-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-24 | 開始されました | UBS | Neutral |
| 2024-08-29 | 開始されました | Barclays | Overweight |
| 2024-04-17 | 開始されました | Jefferies | Buy |
| 2024-04-01 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-02-28 | 再開されました | Guggenheim | Buy |
| 2024-02-23 | 開始されました | Robert W. Baird | Outperform |
| 2023-09-27 | 開始されました | Stifel | Buy |
| 2023-08-08 | 開始されました | SVB Securities | Market Perform |
| 2023-07-24 | 開始されました | Guggenheim | Buy |
| 2023-01-18 | 開始されました | Wedbush | Outperform |
| 2022-06-24 | 開始されました | BMO Capital Markets | Outperform |
すべてを表示
Nuvalent Inc (NUVL) 最新ニュース
What drives Nuvalent Inc. stock priceExceptional earning trajectories - Jammu Links News
How high can Nuvalent Inc. stock price go in 2025Free Access to Community with 300% Return - newser.com
Nuvalent(NUVL) Shares Soar 3.01% on Positive Clinical Data - AInvest
Nuvalent, Inc. (NASDAQ:NUVL) Stock Position Decreased by Teacher Retirement System of Texas - Defense World
Why Nuvalent Inc. stock attracts strong analyst attentionDaily Trade Opportunity - newser.com
How Nuvalent Inc. stock performs during market volatilityFree Capital Allocation Plans - newser.com
What makes Nuvalent Inc. stock price move sharplyFree Access to Stock Community - Newser
Recent Analysts’ Ratings Updates for Nuvalent (NUVL) - Defense World
Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Insider Sells $439,890.00 in Stock - Defense World
Nuvalent's Insider Sales and Clinical Milestones: A Balancing Act for Investors - AInvest
Nuvalent(NUVL) Shares Soar 3.47% on Positive Lung Cancer Data - AInvest
Nuvalent’s SWOT analysis: biotech stock’s pivotal year ahead By Investing.com - Investing.com Nigeria
Nuvalent’s SWOT analysis: biotech stock’s pivotal year ahead - Investing.com
Nuvalent Announces Positive Pivotal Data for Zidesamtinib in Lung Cancer - Insider Monkey
10 Best High Short Interest Stocks With Huge Upside Potential - Insider Monkey
Nuvalent (NUVL) Gets a Buy from Goldman Sachs - The Globe and Mail
Nuvalent (NASDAQ:NUVL) Upgraded at The Goldman Sachs Group - Defense World
Goldman Sachs initiates coverage on Nuvalent stock with Buy rating By Investing.com - Investing.com India
Nuvalent chief development officer Noci sells $314k in shares - Investing.com
Barclays Sticks to Its Buy Rating for Nuvalent (NUVL) - The Globe and Mail
Nuvalent Believes Safety Profile Can Help Zidesamtinib Be ROS-1 Lung Cancer Leader - insights.citeline.com
Nuvalent stock price target raised to $114 from $100 at UBS - Investing.com
Transcript : Nuvalent, Inc.Special Call - MarketScreener
Nuvalent Reports Positive Pivotal Data From ARROS-1 Study Of Zidesamtinib - Nasdaq
Breakthrough Data Coming: Nuvalent's ROS1 Inhibitor Results in Treatment-Resistant Lung Cancer - Stock Titan
Nuvalent Appoints Christy Oliger to Board of Directors - The Malaysian Reserve
Nuvalent appoints former Genentech oncology executive to board - Investing.com
Nuvalent appoints Christy Oliger to board of directors - MarketScreener
Nuvalent Adds Former Genentech Oncology SVP to Board Ahead of 2026 Launch Plans | NUVL Stock News - Stock Titan
Nuvalent’s SWOT analysis: biotech stock poised for pivotal year in NSCLC treatment - Investing.com
GAMMA Investing LLC Boosts Stake in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
(NUVL) Long Term Investment Analysis - news.stocktradersdaily.com
Rhumbline Advisers Acquires 2,572 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Nuvalent’s SWOT analysis: brain-penetrant TKIs poised to reshape NSCLC stock By Investing.com - Investing.com South Africa
Nuvalent’s SWOT analysis: brain-penetrant TKIs poised to reshape NSCLC stock - Investing.com India
Nuvalent Inc. Maintains Momentum Amid Leadership Shift: A Strong Buy on Upcoming Catalysts - AInvest
Nuvalent Highlights Pipeline Progress and Reports Second Quarter 2023 Financial Results - Seeking Alpha
Nuvalent board member Emily Conley resigns By Investing.com - Investing.com Nigeria
Nuvalent board member Emily Conley resigns - Investing.com
Nuvalent Board Member Emily Conley Resigns - TipRanks
How the (NUVL) price action is used to our Advantage - news.stocktradersdaily.com
Nuvalent, Inc. Reports Q1 2025 Financial Results - TipRanks
Nuveen Asset Management LLC Has $6.62 Million Stock Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Nuvalent to Present Preliminary Data from ALKOVE-1 Phase 1/2 Clinical Trial of NVL-655 at 35th AACR-NCI-EORTC Symposium - The Globe and Mail
Nuvalent (NUVL) Stock on the Rise: Decoding the 4.7% Surge and Price Potential - Daily Chhattisgarh News
Nuvalent’s SWOT analysis: cancer drug developer’s stock faces pivotal year By Investing.com - Investing.com Nigeria
Nuvalent’s SWOT analysis: cancer drug developer’s stock faces pivotal year - Investing.com Australia
Deutsche Bank AG Has $2.79 Million Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Nuvalent, Inc. (NASDAQ:NUVL) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Nuvalent, Inc. (NASDAQ:NUVL) Shares Acquired by Bank of America Corp DE - Defense World
BNP Paribas Financial Markets Acquires Shares of 17,366 Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Nuvalent Inc (NUVL) 財務データ
収益
当期純利益
現金流量
EPS
Nuvalent Inc (NUVL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Balcom Alexandra | Chief Financial Officer |
Jul 15 '25 |
Option Exercise |
18.93 |
5,300 |
100,329 |
67,034 |
| Balcom Alexandra | Chief Financial Officer |
Jul 16 '25 |
Sale |
85.10 |
14,700 |
1,250,970 |
61,734 |
| Balcom Alexandra | Chief Financial Officer |
Jul 15 '25 |
Sale |
83.50 |
5,300 |
442,526 |
61,734 |
| Porter James Richard | President and CEO |
Jul 15 '25 |
Option Exercise |
18.93 |
27,000 |
511,110 |
276,062 |
| Porter James Richard | President and CEO |
Jul 15 '25 |
Sale |
82.27 |
27,000 |
2,221,419 |
249,062 |
0.86%
0.10%
大文字化:
|
ボリューム (24 時間):